Clinical trial · Observational
Male breAsT cAncer preDisposition Factor
NCT06219187CI-TRIAL-00114290MATADORcompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a non-interventional, prospective, single-center study designed to collect and describe environmental and psychosocial data from patients with a history of male breast cancer (MBC) referenced in the IUCT-O regional database. The study will be conducted on a population of 110 to 150 patients.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Questionnaire completion | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Male breast cancer
- interventionNames
- Other: Questionnaire completion
Primary outcomes (2)
- measure
- The environmental data in the questionnaire will be described by the usual descriptive statistics.
- timeFrame
- 15 days for each patient
- description
- A 75-question questionnaire will cover such aspects as the patient's living conditions, professional situation, qualifications or level of education, social environment, early life and family environment, general health and recent significant events. Quantitative data will be described by the median, minimum, maximum and number of missing data, and qualitative data by the numbers, percentages and number of missing data for each modality.
- measure
- Psychosocial data from the questionnaire will be described using standard descriptive statistics.
- timeFrame
- 15 days for each patient
- description
- A 75-question questionnaire will cover such aspects as the patient's living conditions, professional situation, qualifications or level of education, social environment, early life and family environment, general health and recent significant events. Quantitative data will be described by the median, minimum, maximum and number of missing data, and qualitative data by the numbers, percentages and number of missing data for each modality.
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Male patient with a personal history of breast cancer 2. Age ≥ 18 years 3. Patient who has had an oncogenetic consultation at IUCT-O and is registered in the IUCT-O oncogenetic database 4. Patient for whom no pathogenic variant has been detected on the HBOC panel (HBOC-) 5. Patient with no objection to participation in the trial (for deceased patients: trusted support person with no objection to participation). Exclusion Criteria: 1\. Patient who has forfeited his/her freedom by administrative or legal award or who is under legal protection (curatorship and guardianship, protection of justice).
References
Publications (0)
Data not yet available
No reference posted for this study.